home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Getting Into the CNS

  June, 19 2009 7:48
your information resource in human molecular genetics

Clues as to how leukaemia cells can get into the central nervous system (CNS) are reported in Nature. It's hoped that the findings could reveal new drug targets to stop cancer spread.

T-cell acute lymphoblastic leukaemia (T-ALL) is a blood cancer that mainly affects children and adolescents, and is often associated with spread to the CNS. Patients are usually given intensive irradiation to the brain in attempt to prevent this - a drastic measure for which the increase in survival is thought to outweigh the significant side-effects.

Iannis Aifantis and colleagues developed a mouse model of T-ALL to explore the signals that help these cancer cells to cross into the CNS. They show that the chemokine receptor CCR7 is crucial for getting the T-ALL cells into the CNS. The binding partner of CCR7, CCL19, is also implicated, and the authors believe that blocking their interaction opens an exciting therapeutic window for preventing CNS spread.


Iannis Aifantis (New York University School of Medicine, New York, NY, USA)
E-mail: iannis.aifantis@nyumc.org

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.